315 related articles for article (PubMed ID: 26328949)
1. In silico ADME/T modelling for rational drug design.
Wang Y; Xing J; Xu Y; Zhou N; Peng J; Xiong Z; Liu X; Luo X; Luo C; Chen K; Zheng M; Jiang H
Q Rev Biophys; 2015 Nov; 48(4):488-515. PubMed ID: 26328949
[TBL] [Abstract][Full Text] [Related]
2. ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd H; Gifford E
Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
[TBL] [Abstract][Full Text] [Related]
3. Structure-ADME relationship: still a long way to go?
Hou T; Wang J
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
[TBL] [Abstract][Full Text] [Related]
4. In silico ADME/Tox: the state of the art.
Ekins S; Rose J
J Mol Graph Model; 2002 Jan; 20(4):305-9. PubMed ID: 11858639
[TBL] [Abstract][Full Text] [Related]
5. In silico ADME-Tox modeling: progress and prospects.
Alqahtani S
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
[TBL] [Abstract][Full Text] [Related]
6. Progress in predicting human ADME parameters in silico.
Ekins S; Waller CL; Swaan PW; Cruciani G; Wrighton SA; Wikel JH
J Pharmacol Toxicol Methods; 2000; 44(1):251-72. PubMed ID: 11274894
[TBL] [Abstract][Full Text] [Related]
7. In silico ADME prediction: data, models, facts and myths.
Lombardo F; Gifford E; Shalaeva MY
Mini Rev Med Chem; 2003 Dec; 3(8):861-75. PubMed ID: 14529504
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
Khakar PS
Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
[TBL] [Abstract][Full Text] [Related]
9. Applying machine learning techniques for ADME-Tox prediction: a review.
Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
[TBL] [Abstract][Full Text] [Related]
10. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
[TBL] [Abstract][Full Text] [Related]
11. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
Gombar VK; Silver IS; Zhao Z
Curr Top Med Chem; 2003; 3(11):1205-25. PubMed ID: 12769701
[TBL] [Abstract][Full Text] [Related]
12. Improving early drug discovery through ADME modelling: an overview.
Wishart DS
Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426
[TBL] [Abstract][Full Text] [Related]
13. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
Moda TL; Torres LG; Carrara AE; Andricopulo AD
Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
[TBL] [Abstract][Full Text] [Related]
14. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
15. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
Fortuna A; Alves G; Soares-da-Silva P; Falcão A
Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
[TBL] [Abstract][Full Text] [Related]
17. A model validation and consensus building environment.
Abshear T; Banik GM; D'Souza ML; Nedwed K; Peng C
SAR QSAR Environ Res; 2006 Jun; 17(3):311-21. PubMed ID: 16815770
[TBL] [Abstract][Full Text] [Related]
18. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development.
Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F
J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624
[TBL] [Abstract][Full Text] [Related]
19. Predicting ADME properties in silico: methods and models.
Butina D; Segall MD; Frankcombe K
Drug Discov Today; 2002 Jun; 7(11):S83-8. PubMed ID: 12047885
[TBL] [Abstract][Full Text] [Related]
20. Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases.
Smith PA; Sorich MJ; Low LS; McKinnon RA; Miners JO
J Mol Graph Model; 2004 Jul; 22(6):507-17. PubMed ID: 15182810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]